Sort
50,496 grants matching “lung cancer”
Immune Therapy for Brain Metastasis
$557,726Lucia Beatrice Jilaveanu · Yale University · R01 · FY2025 · CA
Adenocarinoma of the Lung in Women
$557,707Wayne State University · R01 · FY2001 · CA
Rapid Automated High-Throughput Radiation Biodosimetry
$557,694David Jonathan Brenner · Columbia University Health Sciences · U19 · FY2016 · AI
University of Texas PDX Development and Trial Center
$557,633Jack Roth · University Of Tx Md Anderson Can Ctr · U54 · FY2022 · CA
CatheterScope for Intraluminal Image of Early.Neoplasia
$557,608University Of Washington · R33 · FY2004 · CA
Development of novel protein-based therapeutics for lung cancer
$557,605Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2019 · CA
Therapeutic strategies against EGFR exon 20 mutant lung cancer
$557,481John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Development of a translational imaging tool as a predictive biomarker for anti-PD-1/PD-L1 immunotherapies
$557,470Michael John Evans · University Of California, San Francisco · R01 · FY2021 · EB
Targeting SMARCA2 in SMARCA4-deficient lung cancers in vivo
$557,418Carla P Concepcion-Crisol · Columbia University Health Sciences · R37 · FY2025 · CA
P2: Defining and Visualizing Effects of Costimulation on Antiviral Immunity
$557,357Arlene H Sharpe · Harvard Medical School · P01 · FY2015 · AI
A critical role for macrophage ferroptosis in promoting fungal invasion in lung transplant recipients
$557,332Joe L Hsu · Stanford University · R01 · FY2024 · HL
Background free amplified single-molecule FISH for in situ and flow cytometric applications
$557,328Sanjay Tyagi · Rbhs-New Jersey Medical School · R01 · FY2021 · CA
Background free amplified single-molecule FISH for in situ and flow cytometric applications
$557,328Sanjay Tyagi · Rbhs-New Jersey Medical School · R01 · FY2020 · CA
Validation and Translation of MasSpec Pen Technology for Intraoperative Evaluation of Non-small Cell Lung Cancer
$557,296Livia Schiavinato Eberlin · Baylor College Of Medicine · R01 · FY2024 · CA
Varicella virus antigens in glioma etiology and survival
$557,291Joseph Leo Wiemels · University Of California, San Francisco · U01 · FY2015 · CA
Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor Immunity
$557,274David G Denardo · Washington University · R01 · FY2022 · CA
MeV: Software for Next Generation Genomic Data Analysis
$557,262John Quackenbush · Dana-Farber Cancer Inst · U01 · FY2014 · CA
Arsenic carcinogenesis and disruption of histone variant H3.3 assembly
$557,241Chunyuan Jin · New York University School Of Medicine · R01 · FY2020 · ES
Novel radioimmunoconjugates for targeted alpha-particle therapy of metastatic prostatic cancer
$557,186Jiang He · University Of Virginia · R01 · FY2021 · CA
Mucosal determinants of Cryptosporidium infection
$557,143Pablo C Okhuysen · Baylor College Of Medicine · U19 · FY2022 · AI
Viral Diversity and Pathogenicity in Mucosal Respiratory and Gastrointestinal Disease
$557,143Mary Kolb Estes · Baylor College Of Medicine · U19 · FY2022 · AI
Mucosal determinants of Cryptosporidium infection
$557,142Pablo C Okhuysen · Baylor College Of Medicine · U19 · FY2023 · AI
Viral Diversity and Pathogenicity in Mucosal Respiratory and Gastrointestinal Disease
$557,142Mary Kolb Estes · Baylor College Of Medicine · U19 · FY2023 · AI
Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons
$557,051Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2015 · CA
Improving CAR-T efficacy against solid tumors by expanding lymph node reservoirs of âstem-likeâ CAR-T cells
$557,041Shivani Srivastava · Fred Hutchinson Cancer Center · R37 · FY2024 · CA